Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eileen H. Shinn is active.

Publication


Featured researches published by Eileen H. Shinn.


Journal of Clinical Oncology | 2004

Predictors of Sexual Functioning in Ovarian Cancer Patients

Cindy L. Carmack Taylor; Karen Basen-Engquist; Eileen H. Shinn; Diane C. Bodurka

PURPOSE To characterize sexual functioning of ovarian cancer patients and identify factors predicting sexual activity, functioning or satisfaction, discomfort, and habit or frequency. PATIENTS AND METHODS Data were collected on 232 women with epithelial ovarian cancer, 47% of whom were receiving treatment. RESULTS Fifty percent of the patients had engaged in sexual activity in the past month. Of those who were sexually active, 47% reported no or little desire, 80% reported problems with vaginal dryness, and 62% reported pain or discomfort during penetration. Of those who were sexually inactive, reasons included no partner (44.1%), lack of interest (38.7%), physical problems making sex difficult (23.4%), and fatigue (10.8%). Partner factors also were identified, including physical problems (16.2%), lack of interest (15.3%), and fatigue (5.4%). A multivariate model was used to predict sexual activity and included demographic, medical, and psychosocial factors as predictors. Women who were married (P <.001), were younger than 56 years (P <.001), were not receiving active treatment (P <.01), had a longer time since original diagnosis (P =.104), and liked the appearance of their bodies (P =.004) were more likely to be sexually active. Univariate analyses indicated that demographic, medical, and psychosocial factors are significantly associated with sexual functioning or satisfaction, sexual discomfort, and sexual frequency or habit. CONCLUSION Sexual rehabilitation for ovarian cancer patients should address management of physical and psychologic symptoms and include the patients partner when appropriate.


Archives of Otolaryngology-head & Neck Surgery | 2013

Eat and Exercise During Radiotherapy or Chemoradiotherapy for Pharyngeal Cancers: Use It or Lose It

Katherine A. Hutcheson; Mihir K. Bhayani; Beth M. Beadle; Kathryn A. Gold; Eileen H. Shinn; Stephen Y. Lai; Jan S. Lewin

IMPORTANCE Data support proactive swallowing therapy during radiotherapy (RT) or chemoradiotherapy (CRT) for pharyngeal cancers. The benefits of adherence to a regimen of swallowing exercises and maintaining oral intake throughout treatment are reported, but independent effects are unclear. OBJECTIVE To evaluate the independent effects of maintaining oral intake throughout radiotherapy and adherence to preventive swallowing exercise. DESIGN Retrospective observational study. SETTING The University of Texas MD Anderson Cancer Center, Houston. PATIENTS The study included 497 patients treated with definitive RT or CRT for pharyngeal cancer (458 oropharynx, 39 hypopharynx) between 2002 and 2008. MAIN OUTCOMES AND MEASURES Swallowing-related end points were final diet after RT or CRT and duration of gastrostomy dependence. Primary independent variables included oral intake status at the end of RT or CRT (no oral intake, partial oral intake, or full oral intake) and adherence to a swallowing exercise regimen. Multiple linear regression and ordered logistic regression models were analyzed. RESULTS At the conclusion of RT or CRT, 131 patients (26%) had no oral intake and 74% maintained oral intake (167 partial [34%], 199 full [40%]). Fifty-eight percent (286 of 497) reported adherence to swallowing exercises. Maintenance of oral intake during RT or CRT and swallowing exercise adherence were independently associated with better long-term diet after RT or CRT (P = .045 and P < .001, respectively) and shorter duration of gastrostomy dependence (P < .001 and P = .007, respectively) in models adjusted for tumor and treatment burden. CONCLUSIONS AND RELEVANCE The data indicate independent, positive associations of maintenance of oral intake throughout RT or CRT and swallowing exercise adherence with long-term swallowing outcomes. Patients who either eat or exercise fare better than those who do neither. Patients who both eat and exercise have the highest rate of return to a regular diet and shortest duration of gastrostomy dependence.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2013

Adherence to preventive exercises and self-reported swallowing outcomes in post-radiation head and neck cancer patients

Eileen H. Shinn; Karen Basen-Engquist; George Baum; Sven Steen; Rachel Freeman Bauman; William H. Morrison; Adam S. Garden; Cathleen Sheil; Kelly Kilgore; Katherine A. Hutcheson; Denise A. Barringer; Ying Yuan; Jan S. Lewin

To reduce the risk of long‐term swallowing complications after radiation, swallowing exercises may be helpful. Both the rate of adherence to swallowing exercises and its impact on future swallowing function are unknown.


Cancer | 2009

Glucose as a Prognostic Factor in Ovarian Carcinoma

Donald M. Lamkin; Douglas R. Spitz; Mian M.K. Shahzad; Bridget Zimmerman; Daniel J. Lenihan; Koen DeGeest; David M. Lubaroff; Eileen H. Shinn; Anil K. Sood; Susan K. Lutgendorf

Research suggests that glucose levels in cancer patients may be an important prognostic indicator. In ovarian tumors, increased expression of glucose transporter 1 (GLUT1), a transmembrane protein responsible for glucose uptake, is related to shorter survival time in ovarian cancer patients. This study tested the hypothesis that higher presurgical glucose levels predict shorter disease‐specific survival time and time to recurrence in ovarian cancer patients.


International Journal of Cancer | 2011

Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy

Scott B. Cantor; Jose Miguel Yamal; Martial Guillaud; Dennis D. Cox; E. Neely Atkinson; John L. Benedet; Dianne Miller; Thomas Ehlen; Jasenka Matisic; Dirk van Niekerk; Monique Bertrand; Andrea Milbourne; Helen E. Rhodes; Anais Malpica; Gregg Staerkel; Shahla Nader-Eftekhari; Karen Adler-Storthz; Michael E. Scheurer; Karen Basen-Engquist; Eileen H. Shinn; Loyd A. West; Anne Therese Vlastos; Xia Tao; J. Robert Beck; Calum MacAulay; Michele Follen

Testing emerging technologies involves the evaluation of biologic plausibility, technical efficacy, clinical effectiveness, patient satisfaction, and cost‐effectiveness. The objective of this study was to select an effective classification algorithm for optical spectroscopy as an adjunct to colposcopy and obtain preliminary estimates of its accuracy for the detection of CIN 2 or worse. We recruited 1,000 patients from screening and prevention clinics and 850 patients from colposcopy clinics at two comprehensive cancer centers and a community hospital. Optical spectroscopy was performed, and 4,864 biopsies were obtained from the sites measured, including abnormal and normal colposcopic areas. The gold standard was the histologic report of biopsies, read 2 to 3 times by histopathologists blinded to the cytologic, histopathologic, and spectroscopic results. We calculated sensitivities, specificities, receiver operating characteristic (ROC) curves, and areas under the ROC curves. We identified a cutpoint for an algorithm based on optical spectroscopy that yielded an estimated sensitivity of 1.00 [95% confidence interval (CI) = 0.92–1.00] and an estimated specificity of 0.71 [95% CI = 0.62–0.79] in a combined screening and diagnostic population. The positive and negative predictive values were 0.58 and 1.00, respectively. The area under the ROC curve was 0.85 (95% CI = 0.81–0.89). The per‐patient and per‐site performance were similar in the diagnostic and poorer in the screening settings. Like colposcopy, the device performs best in a diagnostic population. Alternative statistical approaches demonstrate that the analysis is robust and that spectroscopy works as well as or slightly better than colposcopy for the detection of CIN 2 to cancer.


American Journal of Obstetrics and Gynecology | 2003

Patient distress and satisfaction with optical spectroscopy in cervical dysplasia detection

Karen Basen-Engquist; Eileen H. Shinn; A. Carla Warneke; Carl de Moor; Tao Le; Rebecca Richards-Kortum; Michele Follen

OBJECTIVE The aim of this investigation was to evaluate the impact of optical spectroscopy, a new approach for the detection of cervical dysplasia, on patient well-being and satisfaction. STUDY DESIGN Patient distress and satisfaction with optical spectroscopy compared with the Papanicolaou test and colposcopically directed biopsy were measured in a volunteer sample of 314 women with no history of abnormal Papanicolaou test findings. RESULTS Participants reported significantly less pain and anxiety (P<.001) during optical spectroscopy than during the Papanicolaou test or colposcopically directed biopsy. Generally, participants found spectroscopy equal to the Papanicolaou test and to biopsy on a variety of questions that measured satisfaction. There were statistically significant differences between spectroscopy and the Papanicolaou test or biopsy on issues such as the discomfort and fear caused by the test, the amount of time taken, the room lighting, and perceptions of accuracy. CONCLUSION That patients reported less distress during spectroscopy than during a Papanicolaou test, colposcopy, or biopsy suggests the possibility of improved adherence to cervical cancer screening and follow-up in settings in which it is used.


Psychosomatic Medicine | 2016

Depression and oropharynx cancer outcome

Eileen H. Shinn; Alan D. Valentine; Amit Jethanandani; Karen Basen-Engquist; Bryan Fellman; Diana L. Urbauer; E. N. Atkinson; Syed Wamique Yusuf; Daniel J. Lenihan; Myrshia Woods; Merrill S. Kies; Anil K. Sood; Cindy L. Carmack; William H. Morrison; Ann M. Gillenwater; Erich M. Sturgis; Adam S. Garden

Background Studies have shown a modest relationship between depression and mortality in patients with cancer. Our study addressed methodological weaknesses in the literature by restricting the sample to patients with one cancer type, adjusting for factors known to affect outcome, and following up patients for a sufficient period. Methods We prospectively followed patients newly diagnosed with squamous cell oropharyngeal cancer from the start of radiation therapy until death or until date of last clinical visit. All patients were optimally treated with radiation and sometimes chemotherapy. After adjusting for tumor stage, treatment, comorbidities, smoking, excessive alcohol use, and demographic factors, we assessed the effects of baseline self-reported depression on overall survival and recurrence. Results One hundred thirty participants were followed for a median of 5 years. The average age was 56 years, and 83% were male. Eighteen participants died during the study and 15 experienced disease recurrence. Self-reported depression was associated with decreased overall survival duration (hazard ratio = 3.6, 95% confidence interval = 1.2–10.8) and disease recurrence (hazard ratio = 3.8, 95% confidence interval = 1.2–12.2) in multivariate analysis. In addition, smoking was associated with disease recurrence. Conclusions Patients with oropharyngeal cancer may benefit from depression screening and evidence-based treatments, if appropriate. Future studies are needed to determine whether depression is an independent prognostic factor of outcome and to elucidate biobehavioral mechanisms involved in patients with oropharyngeal cancer.


Cancer Epidemiology, Biomarkers & Prevention | 2013

Impact of cardiovascular comorbidity on ovarian cancer mortality

Eileen H. Shinn; Daniel J. Lenihan; Diana L. Urbauer; Karen Basen-Engquist; Alan D. Valentine; Laura Palmero; Myrshia Woods; Pooja R. Patel; Alpa M. Nick; Mian M.K. Shahzad; Rebecca L. Stone; Antoinette Golden; E. N. Atkinson; Susan K. Lutgendorf; Anil K. Sood

Background: A retrospective cohort study utilizing prospectively collected data was conducted from August 2003 until March 2008 at M.D. Anderson Cancer Center. It is unknown whether cardiovascular comorbidity and chronic stress impact ovarian cancer outcome, which remains poor despite advances in therapy. The purpose of this study was to determine whether cardiovascular disease and markers that may be associated with stress are also associated with survival in patients with ovarian cancer. Methods: Participants with newly diagnosed epithelial ovarian cancer were followed until time of death or truncation of study period (median follow-up = 4.2 years; n = 271). Tumor characteristics (stage, tumor grade, histology, debulking status), demographic variables, and cardiovascular comorbidity were documented and compared to overall survival. Results: Of the nine cardiovascular events tracked during follow-up, venous thromboembolism [VTE; HR, 3.2; 95% confidence interval (CI), 1.8–5.5] and pulmonary hypertension (HR, 8.5; 95% CI, 3.9–18.7) were associated with shorter survival in multivariate analysis. In addition, high tumor grade, suboptimal cytoreduction, and baseline heart rate (HR, 1.02; 95% CI, 1.01–1.04) were related to decreased survival. Conclusion: Careful management of certain cardiovascular comorbidities may extend survival in patients with ovarian cancer. Our findings suggest that increased baseline heart rate and the development of VTE and pulmonary hypertension after cancer diagnosis may be significant predictors of survival in women with ovarian cancer. Impact: Our study emphasizes the importance of identifying and optimally treating tachycardia, VTE, and pulmonary hypertension in conjunction with cancer therapy. Cancer Epidemiol Biomarkers Prev; 22(11); 2102–9. ©2013 AACR.


International Journal of Technology Assessment in Health Care | 2007

Patient assessment of tests to detect cervical cancer.

Karen Basen-Engquist; Rachel T. Fouladi; Scott B. Cantor; Eileen H. Shinn; Dawen Sui; Mathilde P. Sharman; Michele Follen

OBJECTIVES This study was undertaken to understand how women view characteristics of tests for cervical dysplasia, because these characteristics can affect patient decision-making about screening and follow-up. METHODS We recruited women who participated in a clinical trial of optical spectroscopy for the diagnosis of cervical dysplasia and used conjoint analysis to assess the womens preferences concerning test attributes. One group of women had a history of an abnormal Papanicolaou smear (diagnostic sample), while the other group did not (screening sample). Participants rated pairs of test scenarios that varied on characteristics such as test sensitivity and painfulness. Based on their responses, the relative importance of test sensitivity, specificity, timing of results feedback and treatment, and pain were calculated, and a cluster analysis was done to identify subgroups of participants with different preference patterns. RESULTS In the overall sample, sensitivity was the most important attribute, followed by timing, specificity, and pain. Cluster analysis revealed four distinct groups who placed varying importance on each characteristic. The participants in the cluster for which pain was the most important attribute were more likely to be diagnostic patients, non-white, and have low education levels. They also reported more anxiety and pain during the examination than participants in other clusters. CONCLUSIONS To continue to reduce morbidity and mortality from cervical cancer, developers of new testing procedures should take into account test attributes such as these, which may affect adherence to screening and diagnostic follow-up to further minimize morbidity and mortality from cervical cancer.


Gender Medicine | 2012

Optical technologies and molecular imaging for cervical neoplasia: A program project update

Timon P.H. Buys; Scott B. Cantor; Martial Guillaud; Karen Adler-Storthz; Dennis D. Cox; Clement A. Okolo; Oyedunni Arulogon; Oladimeji Oladepo; Karen Basen-Engquist; Eileen H. Shinn; Jose Miguel Yamal; J. Robert Beck; Michael E. Scheurer; Dirk van Niekerk; Anais Malpica; Jasenka Matisic; Gregg Staerkel; Edward N. Atkinson; Luc Bidaut; Pierre Lane; J. Lou Benedet; Dianne Miller; Tom Ehlen; Roderick Price; Isaac F. Adewole; Calum MacAulay; Michele Follen

There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancer-related deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institute-funded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.

Collaboration


Dive into the Eileen H. Shinn's collaboration.

Top Co-Authors

Avatar

Karen Basen-Engquist

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Michele Follen

Brookdale University Hospital and Medical Center

View shared research outputs
Top Co-Authors

Avatar

Adam S. Garden

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Anil K. Sood

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Susan K. Peterson

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Beth M. Beadle

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Emilia Farcas

University of California

View shared research outputs
Top Co-Authors

Avatar

Kevin Patrick

University of California

View shared research outputs
Top Co-Authors

Avatar

Stephanie L. Martch

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Alan D. Valentine

University of Texas MD Anderson Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge